Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases
- 1 June 2003
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (9) , 1271-1276
- https://doi.org/10.1016/s0959-8049(03)00234-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain MetastasesJournal of Clinical Oncology, 2002
- Cancer mortality in the European Union, 1988–1997: The fall may approach 80,000 deaths a yearInternational Journal of Cancer, 2002
- A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaEuropean Journal Of Cancer, 2002
- Current and future developments in the use of temozolomide for the treatment of brain tumoursThe Lancet Oncology, 2001
- Temozolomide in combination with other cytotoxic agentsSeminars in Oncology, 2001
- A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain MetastasesJournal of Neuro-Oncology, 2001
- Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?International Journal of Radiation Oncology*Biology*Physics, 2000
- Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade gliomaCancer Chemotherapy and Pharmacology, 1997
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989